Hinge Health climbs after forecasting FY26 revenue above estimates

Shares of AI health platform Hinge Health HNGE.N up 13.8% at $37.60 premarket after co forecasts FY26 revenue above estimates

Co sees FY26 rev between $732 mln-$742 mln, above analyst est. of $717.41 mln, per data compiled by LSEG

CEO Daniel Perez says strong year‑end sales momentum and record customer wins boosted growth and widened margins

Co posts Q4 rev of $170.7 mln, beating expectation of $156.6 mln; Q4 adj EPS of 49 cents, above estimates of 39 cents

16 out of 17 analysts rate stock "buy" or higher, one "hold"; median PT at $59.50 - data compiled by LSEG

Hinge Health debuted in May 2025 with IPO price of $32; stock down 28.8% YTD